Gilbert Mouzin

USPTO Granted Patents = 38 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 221(Granted Patents)

Location History:

Castres, Tarn, FR (1980 - 1981)
Castre, FR (1984)
Toulouse, FR (1990 - 1995)
Castres, FR (1976 - 2016)

Company Filing History:

Pierre Fabre Cosmetique

Pierre Fabre Medicament

patents

5. 1 out of 1

Argentum Holdings S.a.r.l.

7. 1 out of 832,843

Other

patents

Years Active: 1976-2016

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9486397 - Dermocosmetic compositions based on a synergistic combination of colloidal silver and deoxyribonucleic acid (2016-11-08),

2. 5441980 - Potentialization of pyrethroid by crotamiton which is useful in the (1995-08-15),

3. 5438073 - Dermatological and/or cosmetological composition containing retinoids (1995-08-01),

4. 5376379 - Liposomes of thermal waters stabilized in a DNA gel (1994-12-27),

5. 5059599 - Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their (1991-10-22),

6. 5030451 - Topical slenderizing formulation containing cafeine carboxylic acid (1991-07-09),

7. 4938962 - Heterogeneous topical compositions having a base of microgranules of (1990-07-03),

8. 4734417 - Lipid- and cholesterol-reducing derivatives of halo-biphenyl primary (1988-03-29),

9. 4677105 - 2-alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-triazines having utility as (1987-06-30),

10. 4605654 - 2-(arylalkyloxymethyl)morpholines and the central nervous system (1986-08-12),

11. 4567288 - 1-Aryl 2-aminomethyl cyclopropane carboxylates (Z) (1986-01-28),

12. 4539413 - Preparation of 3-amino-1-[(1,4-benzodioxan)-2-yl-methoxy]-2-propanols (1985-09-03),

13. 4511566 - 2-N-Cycloalkylmethyl 3-oxo 5,6-diaryl-as-triazines (1985-04-16),

14. 4510142 - Derivatives of biphenyl alkyl carboxylates and their use as medicaments (1985-04-09),

15. 4507318 - 1-Aryl 2-aminomethyl cyclopropane carboxylates (Z) as drugs in the (1985-03-26),

Title: Gilbert Mouzin: Paving the Way for Technological Advancements

Introduction:

Meet Gilbert Mouzin, a visionary inventor hailing from Castres, France. His unwavering passion for innovation and relentless pursuit of excellence have cemented his status as a trailblazer in the technological landscape.

Latest Patents:

Gilbert Mouzin boasts an impressive portfolio of 40 patents, highlighting his expertise in cutting-edge inventions. Among his latest patents are innovative dermocosmetic compositions based on a synergistic blend of colloidal silver and deoxyribonucleic acid.

- Dermocosmetic compositions based on a synergistic combination of colloidal silver and deoxyribonucleic acid: Gilbert Mouzin's invention showcases dermocosmetic formulations featuring a unique amalgamation of colloidal silver and DNA, offering groundbreaking solutions for skincare.

- Potentialization of pyrethroid by crotamiton: His inventive dermatological and cosmetological composition for treating pediculosis underscores a novel blend of pyrethroid and crotamiton, revolutionizing treatment approaches in the beauty and wellness industry.

Career Highlights:

Gilbert Mouzin's remarkable journey includes impactful stints at Pierre Fabre S.A. and Pierre Fabre Cosmetique, where his innovative spirit has flourished. His contributions have significantly influenced the technological advancements in the realms of dermatology and cosmetology.

Collaborations:

Throughout his career, Gilbert Mouzin has collaborated with esteemed professionals such as Henri Cousse and Antoine Stenger, fostering a culture of innovation and collaboration. Together, they have pushed the boundaries of conventional thinking and inspired groundbreaking inventions.

Conclusion:

In conclusion, Gilbert Mouzin stands as a beacon of innovation, shaping the future of technology with his transformative inventions. His creative genius and dedication to excellence continue to propel the industry forward, leaving an indelible mark on the global innovation landscape.

This text is generated by artificial intelligence and may not be accurate.